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doi:10.1016/j.jmii.2011.01.025Background: Lower respiratory tract infections (LRTIs) comprise a great proportion of diag-
noses among hospitalized children. This study identifies the viral pathogens causing LRTIs in
young children and compares their clinical features and disease severity.
Methods: Children younger than 36 months old, hospitalized at a medical center in Northern
Taiwan with acute bronchiolitis or pneumonia from April to December 2007, were prospectively
enrolled. Nasopharyngeal aspiration fluid sampleswere sent for virus culture, for direct immuno-
fluorescence test of respiratory syncytial virus (RSV), for rapid influenza viral identification, and
for polymerase chain reaction of humanmetapneumovirus (hMPV), humanboca virus (hBoV), and
human corona virus. The clinical features and laboratory findings were recorded and analyzed.
Results: A total of 48 children were enrolled. RSV was the most common pathogen (41.7%), fol-
lowed by hMPV (27.1%), hBoV, and enterovirus (both 6.3%). Therewere no significant differences
in clinical presentation and disease severity between the RSV and hMPV groups. However, the
hMPV group had a higher mixed infection rate (pZ 0.038). Fourteen children had no identifiable
viruses. Childrenwith single, dual, and triple pathogens numbered 26, 7, and 1, respectively. The
mixed infection rate reached 23.5% among 34 children with identifiable viruses. Children with
a higher severity score had greater chance to develop asthma in the next 2 years (pZ 0.042).of Pediatrics, Mackay Memorial Hospital, 92, Section 2, Chung Shan North Rd, Taipei 10449, Taiwan.
org.tw (N.-C. Chiu).
an Society of Microbiology. Published by Elsevier Taiwan LLC. All rights reserved.
Lower respiratory tract infections in children 185Conclusion: RSV is the most common pathogen causing LRTIs in young children, followed by
hMPV. The hMPV group had higher mixed infection rate than RSV group. hBoV does circulate in
northern Taiwan.
Copyright ª 2011, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Lower respiratory tract infection (LRTI) refers to infections
of the trachea, bronchus, and lungs, including tracheitis,
bronchitis, bronchiolitis, and pneumonia. The most common
viral LRTIs among young children are acute bronchiolitis and
pneumonia. Acute bronchiolitis is characterized by tachyp-
nea, wheezing, suprasternal or intercostal retraction,
sometimes cyanosis or apnea, and even respiratory failure.1
As a virus-predominant disease, the most common acute
bronchiolitis pathogen is respiratory syncytial virus (RSV),
causing more than 50% of cases. Other respiratory patho-
gens include the influenza virus, parainfluenza virus,
adenovirus (ADV), rhinovirus, and enterovirus.2
Human metapneumovirus (hMPV), human bocavirus
(hBoV), and human coronavirus NL-63 (hCoV NL-63) are
three of the novel viruses resulting in similar symptoms to
RSV, including acute wheezing episodes.3,4 Their incidences
among children with LRTI vary between 1.5e17.5%,5
1.5e11.3%,6 and 1.3e9.3%,7,8 respectively. Detection of
these viruses relies on polymerase chain reaction (PCR) in
reference laboratories.
Concomitant detection of two or three respiratory
viruses in one individual could occur. Bonzel et al.9 repor-
ted a 21% mixed infection rate among children with virus
positive acute respiratory infection. The combination of
RSV and hBoV accounts for two-thirds of their mixed
infections. The occurrence of dual infection is a risk factor
of greater disease severity.10 Evidence also showed that
severe viral infection in infancy or early childhood is
related to recurrent wheezing and asthma in later life,
especially RSV and hMPV infections.11
This study explores the epidemiology of viral LRTIs in
young children, including single and mixed infections. We
also tried to sketch the clinical picture of novel respiratory
viruses compared with RSV bronchiolitis.Methods
Patients
The inclusion criteria for this study were: (1) young children
aged younger than 36 months; (2) hospitalization at general
wards or newborn center of Mackay Memorial Hospital, Tai-
pei from April 1 to December 31, 2007; and (3) a diagnosis of
acute bronchiolitis and/or pneumonia. Acute bronchiolitis
was defined as acute episodes of cough, rhinorrhea,
wheezing or rales, with chest X-ray findings of over aeration,
peribronchial infiltration with or without atelectasis. Pneu-
monia was defined as febrile episodes with rales and chest X-
ray findings for airbronchogram or haziness of the lung fields.
Fully informed consents were acquired and patients whose
parents refused to join this project were excluded.Specimens
We prospectively collected oropharyngeal swabs with
sterile cotton buds and nasopharyngeal aspiration (NPA)
fluids from all subjects within 48 hours of admission. The
specimens were preserved in standard transport media
under 4C refrigeration and were transported to the
Department of Clinical Virology and Microbiology Labora-
tory of our hospital for virus culture, antigen detection, and
nucleic acid (NA) amplification. Three to five milliliters of
serum was obtained from each subject for complete blood
counts and C-reactive protein.
Viral identification
The oropharyngeal swabs were inoculated on four cell lines
(MRC-5 from fibroblast of human fetal lung, Hep-2, A549
from laryngeal carcinoma, and RD cell from rhabdomyo-
sarcoma) for isolation of respiratory viruses. The type of
viruses was confirmed by reactions with immunofluorescent
antibodies following typical cytopathic effects.
NPA fluid samples were sent for direct immunofluores-
cence assay to detect RSV (IMAGEN RSV, OXOID, Basing-
stoke, UK) and Influenza A and B (QuickVue Influenza Test,
QUIDEL, San Diego, CA, USA).
The NA amplification method was applied to identify the
three novel respiratory viruses. NAs were extracted from
200 mL of NPA fluid with High Pure Viral Nucleic Acid Kit
(Roche, Basel, Switzerland) and QIAamp Viral RNA Mini Kit
(QIAGEN, Duesseldorf, Germany). For hBoV, PCR was
performed with 2 primers of 188 forward (GACCTCTG
TAAGTACTATTAC) and 542 reverse (CTCTGTGTTGACTGAA
TACAG).12 For hMPV and hCoV NL-63, complementary DNA
was synthesized by using 10 mL of eluted RNA and Advantage
RT-for-PCR kit (Clontech, Mountain View, CA, USA). PCR for
hMPV was performed with two new primers: N1 forward
(TCTACAGGCAGCAAAGCAGA) and N1 reverse (TTTGGG
CTTTGCCTTAAATG), amplifying a 224-bp region on nucleo-
protein (N) gene of hMPV.13 Nested PCR for hCoV NL-63 was
performed with two sets of primers: repSZ-l (GTGATGCA
TATGCTAATTTG) and repSZ-3 (CTCTTGCAGGTATAATCCTA),
repSZ-2 (TTGGTAAACAAAAGATAACT) and repSZ-4
(TGAATGGTATAAACAGTCAT).14
Clinical data
The clinical data of concern included demographic data (age,
sex, and underlying disease), history (past history of atopic
diseases and LRTIs, symptoms and signs contributory to the
diagnosis of bronchiolitis and/or pneumonia, vital signs at
admission, and duration of fever), in-hospital workup
(complete blood counts, C-reactive protein, and chest
X-ray), treatment (type and duration of O2 support), and
outcome (duration of hospitalization and complications).
Table 1 Five-component bronchiolitis clinical score system for rating the severity of acute bronchiolitis15
Score 0 1 2
Duration of hospital stay (d) <3 4e7 >8
Respiratory support Nil O2 tent Respirator
Wheeze Inspiratory phase Inspiratoy and expiratory phase Diminishing breath sounds
Respiratory rate (/min) 20e40 40e60 >60
Dyspnea
Nasal flaring/subcostal retraction Nil Yes, without cyanosis Yes, with cyanosis
186 C.-C. Sung et al.Further development of asthma within 2 years after current
illness according to chart review was recorded. Atopic
diseases referred to atopic dermatitis, allergic rhinitis, and
asthma. Dyspnea was defined as presence of tachypnea,
cyanosis, suprasternal, or intercostal retractions. The
severity of acute bronchiolitis was rated by a 5-component
bronchiolitis clinical score system, modified from Bentur’s15
study in 1992, ranging from 0 to 10 points (Table 1). Mild,
moderate, and severe acute bronchiolitis were defined as
total score of 0e3, 4e7, and 8e10 points, respectively.
Statistic analysis
All data were expressed with mean  standard deviation or
median with range. Categorical data were analyzed using
c2 test or Fisher’s exact test. Intervals and ordinal data
were analyzed using the Mann-Whitney U test. Statistical
significance was defined as a p value less than 0.05.Table 2 Demographic data of patients with acute bronchiolitis
Patient, n (%)
Age (mo)
Gender (male) 30 (62.5)
Underlying disease
Pulmonary 4
Extrapulmonary 2
Past history
Asthma 3
Atopy 6
Acute bronchiolitis 7
Duration of hospitalization (d)
Fever 37 (77.0)
Duration of fever (d)
Highest temperature (C)
Dyspnea 33 (68.8)
O2 support (O2 hood) 42 (87.5)
Duration of O2 support (d)
White blood cell counts (1,000/mL)
Eosinophil counts (mL)
C-reactive protein (mg/dL)
Bronchiolitis clinical score
Complication
Croup 2
Acute otitis media 9
Sinusitis 6
Pneumonia 12 (25.0)
Newly developed asthmaa 13 (27.1)
a Asthma was diagnosed during the follow-up period.Results
A total of 48 children aged 2e32 months (mean 11.6  7.7
months) were enrolled and followed up for at least 2 years
(till December, 2009). There were 30 males and 18 females
with a male-to-female ratio of 1.6 to 1. The diagnoses
were acute bronchiolitis (36 patients, 75%), pneumonia (4
patients, 8.3%) or both (8 patients, 16.7%). Detailed
demographic data were showed in Table 2. All patients
achieved full recovery without long-term sequelae.
According to the chart review, 13 children had newly
diagnosed asthma during the follow-up period.
A total of 33 children’s specimens underwent both virus
culture and PCR procedure. Among them, 11 children had
identifiable viruses with virus culture (virus yield rate:
33.3%), whereas an additional 7 children were found to
have novel respiratory viruses with PCR methods (overall
virus yield rate: 54.5%).or pneumonia
Range Mean Standard deviation
2.1e32.0 11.6 7.7
3e11 5.2 2.1
1e20 3.9 3.4
38.0e40.9 39.2 1.0
1e9 4.5 2.2
4.7e24.6 11.4 4.2
0e1,608 170 295
0.01e14.80 1.89 3.11
0e7 3.5 1
29.2%
41.7%
27.1%
6.3% 6.3% 4.2% 2.1% 2.1%
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Figure 1. Identified viruses in children with lower respira-
tory tract infection.
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Forty-three respiratory viruses were detected. The two
most predominant pathogens were RSV and hMPV (Fig. 1).
Comparing the clinical data from these two groups, most
variables showed no significant difference (Table 3), exceptTable 3 Comparison of clinical data between children with resp
RSV (n Z 20)
Age (mo) 9.2 (2.4e27.
Gender
Male 15
Female 5
Underlying disease 0
Past history
Asthma 2
Atopy 4
Acute bronchiolitis 1
Mixed infection 6 (30%)
Duration of hospitalization (d) 4.5(3e9)
Fever 16
Duration of fever (d) 4 (1e8)
Highest temperature(C) 39.0 (38.2e4
Dyspnea 16
O2 support (O2 hood) 19
Duration of O2 support (d) 4 (0e9)
Respiratory rate (/min) 32 (25e56)
Heart rate (/min) 134 (114e156
White blood cell counts (1,000/mL) 9.25 (5.0e18
Eosinophil counts (mL) 36 (0e564)
C-reactive protein (mg/dL) 0.52 (0.04e9
Hemoglobin (g/dL) 12.0 (10.1e1
Platelet (K/mL) 306 (169e495
Bronchiolitis clinical score 4 (2e5)
Mild (0e4) 14
Moderate (5e8) 6
Associated condition
Acute otitis media 3
Sinusitis 3
Pneumonia 5
Newly developed asthmaa 5
a Asthma was diagnosed during the follow-up period.
ASDII Z Atrial septal defect type II; hMPV Z human metapneumoviruthat mixed infection with other respiratory viruses was
more common in the hMPV group (p Z 0.038). There was
a trend toward longer O2 demand in RSV-infected children
than hMPV-infected ones (pZ 0.053). No any hCoV NL-63 or
influenza virus was identified in our patients.
Type of infection
The numbers of patients with 0, 1, 2, and 3 kinds of viruses
identified were 14, 26, 7, and 1, respectively (Fig. 2). Mixed
infection comprised 23.5% of 34 children with identifiable
viruses. The clinical features of patientswith single andmixed
infection are shown in Table 4. Dual infections occurred in RSV
with hMPV (two patients), hBoV (one patient), or HSV (one
patient), aswell as in hMPVwith hBoV (one patient), ADV (one
patient) or parainfluenza virus3 (one patient). One patient
had RSV, hMPV, and ADV identified at the same time.
Correlation between LRTI and asthma
Children with higher bronchiolitis clinical scores had higher
chance to have asthma in later life (pZ 0.042). Its odds ratio
for asthmawas 4.33 (95% confidence intervalZ 1.16e16.26).iratory syncytial virus and human metapneumovirus infection
hMPV (n Z 13) p
7) 11.0 (2.1e32.1) 0.796
7
6 0.270
1 (ASDII)
2 1.000
2 1.000
1 1.000
9 (69%) 0.038
4 (2e10) 0.267
10 1.000
2.5 (1e6) 0.412
0.9) 39.6 (38.7e40.0) 0.969
8 0.425
10 0.276
2 (0e5) 0.053
30 (22e50) 0.454
) 140 (116e160) 0.985
.8) 9.4 (4.7e16.6) 0.580
58 (0e332) 0.830
.01) 0.35 (0.01e2.21) 0.417
4.1) 11.5 (9.2e12.9) 0.209
) 409 (184e678) 0.074
3 (0e5) 0.151
11
2 0.431
1 1.000
1 1.000
3 1.000
5 0.461
s; RSV Z respiratory syncytial virus.
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Figure 2. Numbers of identified virus in children with lower
respiratory tract infection.
188 C.-C. Sung et al.However, the odds ratios of RSVand hMPV infection to asthma
in later life were 0.52 (95% confidence intervalZ 0.15e1.83)
and1.36 (95%confidence intervalZ0.36e5.13), respectively.Discussion
With the development of PCR techniques, novel respiratory
viruses are being found, allowing us to better explore the
picture of acute respiratory tract infections. So far, PCR-
based surveys on the epidemiology of young children LRTIsTable 4 Comparison of clinical data between children with sin
Single inf
Age (mo) 11.2 (4.1
Gender
Male 21
Female 5
Past history
Asthma 3
Atopy 4
Acute bronchiolitis 3
Duration of hospitalization (d) 5.2 (3.1e
Fever 21
Duration of fever (d) 3.4 (1.2e
Highest temperature (C) 39.2 (38.
Dyspnea 20
O2 support (O2 hood) 25
Duration of O2 support (d) 4.4 (2.1e
Respiratory rate (/min) 37 (26e4
Heart rate (/min) 135 (122e
White blood cell counts (1,000/mL) 10.4 (6.2
Eosinophil counts (/mL) 178 (0e4
C-reactive protein (mg/dL) 1.65 (0e
Hemoglobin (g/dL) 11.8 (10.
Platelet (K/mL) 315 (229e
Bronchiolitis clinical score 3.8 (2.8e
Mild (0e4) 17
Moderate (5e8) 9
Associated condition
Acute otitis media 6
Sinusitis 4
Pneumonia 5
Newly developed asthmaa 7
a Asthma was diagnosed during the follow-up period.in Taiwan have been limited.7,16,17 The present study
described the incidence, demographic characteristics, and
clinical characteristics of LRTIs caused by various viruses. In
one recent PCR-based study on children below 2 years old
with acute bronchiolitis, the viral isolation rate elevated
from 48% to 90% after applying PCR technique in addition to
traditional virus culture.2 Another study enrolled 182
infants hospitalized with acute bronchiolitis showed a rise
in virus yield rate from 42.3% to 57.2%.18 In our study, the
virus yield rate was 33.3% with virus culture and 54.5% with
additional PCR methods. These results suggest that PCR
technique is a promising tool in clinical virology studies,
helping researchers to explore viral diseases in a more
comprehensive perspective.
As in the previous literature, RSV is always the leading
pathogen of acute bronchiolitis. The isolation rate varies
with different study designs and geographic areas. Mlinaric-
Galinovic et al.18 reported that RSV was responsible for 49%
of 1,010 hospitalized Croatian infants with LRTI and younger
than 6 months old over an 11-year period. In the study of
Miron et al.2 in Israel, 490 previously healthy babies younger
than 24 months hospitalized for acute bronchiolitis during 4
winter months were enrolled. RSV was identified in 76% of
children. Midulla et al.19 found RSV in 41.2% of 182 Italian
infants with acute bronchiolitis in three consecutive annual
epidemic periods. In our study, RSV was the most frequentlygle and mixed infection
ection (n Z 26) Mixed infection (n Z 8)
e18.3) 13.8(5.1e22.6)
3
5
1
2
0
7.4) 3.8 (2.9e4.6)
7
5.6) 3.4 (1.9e4.9)
3e40.0) 39.3 (38.9e39.7)
4
6
6.6) 2.5 (0.5e4.5)
7) 36 (27e44)
147) 132 (122e146)
e14.5) 10.9 (6.8e15.0)
98) 48 (0e114)
4.06) 0.82 (0e1.67)
6e13.0) 11.6 (11.0e12.2)
402) 415 (279e550)
4.8) 2.6 (0.6e4.6)
7
1
0
0
3
3
Lower respiratory tract infections in children 189detected virus, presented in 41.7% of all patients. RSV in
Taiwan circulates year-round and peaks mainly in spring and
fall with annual variation.20 Thus, if we enrolled patients
over 12 months the incidence of RSV may change.
hMPV isolation has been reported around the world since
2001,21,22 with various prevalence from 1.5% to 17.5% in
children hospitalized with acute respiratory illness.
However, hMPV-positive patients accounted for up to 27.1%
in our study, which may be related to N gene use with higher
sensitivity in hMPV detection. Regarding the difference
between RSV and hMPV, Chan et al. reported that RSV-
infected children at a younger age lead to longer hospital
stays and higher oxygen demand than hMPV did.23 On the
other hand, Viazov reported that the clinical characters of
RSVand hMPV bronchiolitis showed no significant difference,
except the duration of symptoms was shorter in hMPV-
infected patients.24 Mullins’ data showed similar disease
severity in RSV and hMPV-infected children.25 No significant
difference was found in hospital stay or fever duration,
severity score, white blood cell counts, C-reactive protein,
or complication rate in our study, similar to Carraciolo’s
report.26 However, RSV-positive patients showed a trend for
longer duration of O2 demand (pZ 0.053). The discrepancy
among these studies may result from the great hetero-
genecity in studied populations (age group, diagnosis, and
inpatient/outpatient). To differentiate these two viruses
judging by clinical information is difficult. Therefore,
further researches with large sample sizes and detailed
subgroup analyses are necessary.
The prevalence of hBoV varies considerably between 1.5
and 11.3% in children suffering from acute respiratory
infections.6 In addition to LRTIs, it can cause wheezing,
respiratory distress, hypoxia, fever, rhinitis, and laryngeal
croup in children.27 A high rate of coinfection with other
respiratory viruses (up to 91% in Thailand6) makes it diffi-
cult to clarify the pathogenic role of hBoV. In the Italian
report, hBoV was isolated in 8.2% of patients, including
61.8% of coinfection with various viruses, which resulted in
difficulties in defining the true causative virus.28 Dina
et al.29 reported a 1.6% incidence of hBoV in hospitalized
children in France, with coinfection presented in four of
seven hBoV-positive children. The prevalence rate of hBoV
in our study was 6.25%, and two of the three hBoV-positive
patients had more than one pathogen identified (coinfected
with RSV and hMPV, respectively). This result suggests that
hBoV does circulate in our community.
hCoV NL-63 has been reported to play a role in acute
respiratory tract infection in infants and children, with
a percentage from 1.3% in Taiwan7 and up to 9.3% in France.8
It is more likely to present as croup or acute bronchiolitis,30
but pharyngitis, rhinitis, otitis, conjunctivitis, and pneu-
monia are all within its clinical spectrum. The present study
failed to identify any one patient with hCoV NL-63, which
may result from its relative low incidence and small sample
size.
Simultaneous existence of more than one virus in an
individual patient has been reported, with a mixed infec-
tion rate ranges from 10% to 30% among hospitalized chil-
dren, mostly RSV-hMPV and RSV-rhinovirus.9,19,26,31 In the
present study, the mixed infection rate was 16.7% (8 of 48
patients). Furthermore, 30% of RSV-positive (6 of 20) and
69% of hMPV-positive (9 of 13) patients had more than onevirus identified. The rate of mixed infection is significantly
higher in hMPV group (p Z 0.038). In previous literatures,
the frequency of hMPV and RSV coinfection ranges from 0 to
20%.32 Whether a mixed infection causes more severe
disease is still controversial. Some reported that simulta-
neous infection with RSV and hMPV was related to higher
severity,10 whereas the other did not.32 We found no
significant difference in severity (duration of hospitaliza-
tion, fever, O2 support, and severity score) among RSV,
hMPV, and RSV/hMPV groups. A larger population is needed
for clarifying the correlation between dual infection and
disease severity.
It is reported that severe viral respiratory infections are
more likely to have asthma later in childhood.11 We found
that high severity score is a risk factor of asthma with an
odds ratio of 4.33. Although limited data were not sufficient
to identify the correlation between individual viral path-
ogen and asthma, it seemed to be certain of the severe
LRTIs effect on the development of asthma. Long-term
follow-up and expansion to intensive care unit patients are
necessary to get more concrete conclusion.
There are a few limitations in our study. The small-sized
population lowers the probability of catching statistical
difference and precludes detailed subgroup analysis. A
relatively short study period impedes observation of sea-
sonality and may affect the distribution of viruses. Because
not many influenza infections occurred in Taiwan during the
study period, it could explain why we did not detect the
influenza virus. The exclusion of outpatients and intensive
care unit patients leads to a conclusion applied to a specific
range of disease severity.
In conclusion, with limited PCR-based studies on viral
respiratory tract infections in Taiwan, the present study
pictures viral epidemiology in young hospitalized children
with the focus on novel respiratory viruses. RSV is the most
common as a single pathogen, followed by hMPV, which
had significantly higher rate of coinfection compared with
RSV. Otherwise, the clinical characteristics of hMPV do not
significantly differ from those of RSV. Mixed infection was
noted in 23.5% of patients with identifiable viral patho-
gens. hBoV does circulate in the population of Northern
Taiwan.
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